Literature DB >> 6144721

Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients.

J P McEvoy, A C Howe, G E Hogarty.   

Abstract

Two subgroups of relapsed and rehospitalized schizophrenic patients were separated on the basis of preadmission compliance or noncompliance with prescribed antipsychotic medications. Noncompliant patients had a gradual onset of episode with prominent psychotic features, required involuntary commitment, and remained in hospital longer. Compliant patients had a rapid onset of symptoms with prominent affective features (anxiety and depression) which were frequently associated with environmental stressors independent of the patient. Compliant patients were usually voluntary admissions and recovered quickly with minimal or no change in their antipsychotic pharmacotherapy. The pathogenesis of relapse among drug-compliant patients remains unknown, but likely includes aspects of environmental stress, an emergent affective syndrome, and, to some less clear extent, akinesia and akathisia. Implications for the inpatient and community treatment of these patients are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144721     DOI: 10.1097/00005053-198407000-00007

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  14 in total

1.  Psychometric properties of the Taiwanese version of the Illness Concept Scale: relation of health beliefs to psychopathology and medication compliance.

Authors:  Yu-Chen Kao; Yia-Ping Liu; Ming-Kuen Chou; Tsung-Hsing Cheng
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-04       Impact factor: 4.328

2.  Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia.

Authors:  Kenneth L Subotnik; Keith H Nuechterlein; Joseph Ventura; Michael J Gitlin; Stephen Marder; Jim Mintz; Gerhard S Hellemann; Leslie A Thornton; Indira R Singh
Journal:  Am J Psychiatry       Date:  2011-01-04       Impact factor: 18.112

Review 3.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

4.  Risk of readmission in compulsorily and voluntarily admitted patients.

Authors:  Avi Valevski; Mark Olfson; Abraham Weizman; Roni Shiloh
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-08-21       Impact factor: 4.328

5.  An approach to maximizing treatment adherence of children and adolescents with psychotic disorders and major mood disorders.

Authors:  Robin Edward Gearing; Irfan A Mian
Journal:  Can Child Adolesc Psychiatr Rev       Date:  2005-11

Review 6.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

7.  Perceptions of ADHD Among Diagnosed Children and Their Parents: A Systematic Review Using the Common-Sense Model of Illness Representations.

Authors:  Iana Y T Wong; David J Hawes; Simon Clarke; Michael R Kohn; Ilan Dar-Nimrod
Journal:  Clin Child Fam Psychol Rev       Date:  2018-03

8.  Outpatient antipsychotic treatment and inpatient costs of schizophrenia.

Authors:  Steven C Marcus; Mark Olfson
Journal:  Schizophr Bull       Date:  2007-06-19       Impact factor: 9.306

9.  Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific survey.

Authors:  Jose Manuel Olivares; Manickam Thirunavukarasu; Jayashri Kulkarni; Hong Yan Zhang; Mingyuan Zhang; Fan Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-12       Impact factor: 2.570

10.  Attitudes toward Medication and Reasons for Non-Compliance in Patients with Schizophrenia.

Authors:  Ivatury Sarath Chandra; Kalasapati Lokesh Kumar; Mallepalli Pramod Reddy; Chada Muni Pavan Kumar Reddy
Journal:  Indian J Psychol Med       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.